Literature DB >> 2696327

Immune suppression in HTLV-I carriers: a predictive sign of adult T-cell leukemia.

H Taguchi1, I Miyoshi.   

Abstract

Suppression of the cellular immune system appears to be a prerequisite for the manifestation of adult T-cell leukemia (ATL). In other words, ATL will develop when impairment of the immune system is caused by the infection of human T-lymphotropic virus type I (HTLV-I). This defect of immune surveillance against virus-infected cells may be a result of the impairment of the function of cytotoxic T-cells (CTLs) specific for the HTLV-I-infected cells. The manifestation of ATL could be predicted by examining the function of CTLs in HTLV-I carriers. A new strategy of prevention and therapy for ATL would include an attempt to restore and fortify the CTL function of the host.

Entities:  

Mesh:

Year:  1989        PMID: 2696327     DOI: 10.18926/AMO/30865

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  6 in total

1.  Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.

Authors:  Nicole S Harhaj; Branislava Janic; Juan C Ramos; William J Harrington; Edward W Harhaj
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

2.  Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.

Authors:  I Bastian; J Gardner; D Webb; I Gardner
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

3.  Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.

Authors:  T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 4.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

5.  Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Peter D Burbelo; Elise Meoli; Hannah P Leahy; Jhanelle Graham; Karen Yao; Unsong Oh; John E Janik; Renaud Mahieux; Fatah Kashanchi; Michael J Iadarola; Steven Jacobson
Journal:  Retrovirology       Date:  2008-10-20       Impact factor: 4.602

6.  Interaction of perforin and granzyme B and HTLV-1 viral factors is associated with Adult T cell Leukemia development.

Authors:  Mohammad Mehdi Akbarin; Sadegh Farhadi; Abolghasem Allahyari; Mohammad Mehdi Koshayar; Abbas Shirdel; Hossein Rahimi; Seyed Abdolrahim Rezaee; Maryam Mahdifar; Zahra Mozaheb; Asadollah Mohamadi; Alireza Bari; SeyedehTahereh Mohaddes; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.